Entrada Therapeutics, Inc. · NASDAQ:TRDA

Entrada Therapeutics, Inc. insider trades

Entrada Therapeutics, Inc.'s insiders made 1 buy and 36 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

DateInsiderTradeSharesPriceFiling
Sep 9, 2026MPM BioVentures 2018 GP LLCSale28,837US$7Form 4
Sep 9, 2026Mpm Bioventures 2018 (B), L.P.Sale28,837US$7Form 4
Sep 8, 2026MPM BioVentures 2018 GP LLCSale192,500US$7Form 4
Sep 8, 2026Mpm Bioventures 2018 (B), L.P.Sale192,500US$7Form 4
Sep 4, 2026MPM BioVentures 2018 GP LLCSale38,500US$7Form 4
Sep 4, 2026Mpm Bioventures 2018 (B), L.P.Sale38,500US$7Form 4
Sep 3, 2026MPM BioVentures 2018 LLCSale32,263US$7Form 4
Sep 3, 2026MPM BioVentures 2014 GP LLCSale32,263US$7Form 4
Sep 2, 2026MPM BioVentures 2018 LLCSale25,131US$7Form 4
Sep 2, 2026MPM BioVentures 2014 GP LLCSale25,131US$7Form 4

Entrada Therapeutics, Inc. shareholders